Advertisement
New Zealand markets closed
  • NZX 50

    11,699.79
    -28.27 (-0.24%)
     
  • NZD/USD

    0.6136
    +0.0015 (+0.24%)
     
  • NZD/EUR

    0.5637
    +0.0008 (+0.15%)
     
  • ALL ORDS

    8,082.30
    -67.80 (-0.83%)
     
  • ASX 200

    7,814.40
    -66.90 (-0.85%)
     
  • OIL

    80.00
    +0.77 (+0.97%)
     
  • GOLD

    2,419.80
    +34.30 (+1.44%)
     
  • NASDAQ

    18,546.23
    -11.73 (-0.06%)
     
  • FTSE

    8,420.26
    -18.39 (-0.22%)
     
  • Dow Jones

    40,003.59
    +134.21 (+0.34%)
     
  • DAX

    18,704.42
    -34.39 (-0.18%)
     
  • Hang Seng

    19,553.61
    +177.08 (+0.91%)
     
  • NIKKEI 225

    38,787.38
    -132.88 (-0.34%)
     
  • NZD/JPY

    95.4860
    +0.4250 (+0.45%)
     

Unlocking Q3 Potential of P&G (PG): Exploring Wall Street Estimates for Key Metrics

Wall Street analysts expect Procter & Gamble (PG) to post quarterly earnings of $1.42 per share in its upcoming report, which indicates a year-over-year increase of 3.7%. Revenues are expected to be $20.48 billion, up 2.1% from the year-ago quarter.

The current level reflects a downward revision of 0.3% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.

Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.

While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.

ADVERTISEMENT

Given this perspective, it's time to examine the average forecasts of specific P&G metrics that are routinely monitored and predicted by Wall Street analysts.

The combined assessment of analysts suggests that 'Net sales- Beauty' will likely reach $3.46 billion. The estimate points to a change of -1% from the year-ago quarter.

The average prediction of analysts places 'Net sales- Grooming' at $1.55 billion. The estimate indicates a change of +3.7% from the prior-year quarter.

The collective assessment of analysts points to an estimated 'Net sales- Corporate' of $164.31 million. The estimate indicates a year-over-year change of -5%.

Analysts expect 'Net sales- Fabric & Home Care' to come in at $7.24 billion. The estimate points to a change of +3.1% from the year-ago quarter.

Based on the collective assessment of analysts, 'Net sales- Baby, Feminine & Family Care' should arrive at $5.16 billion. The estimate indicates a year-over-year change of +1.9%.

Analysts' assessment points toward 'Net sales- Health Care' reaching $2.91 billion. The estimate points to a change of +3% from the year-ago quarter.

The consensus estimate for 'Organic Sales Growth (YoY change) - Beauty' stands at 0.5%. The estimate is in contrast to the year-ago figure of 7%.

Analysts predict that the 'Organic Sales Growth (YoY change) - Grooming' will reach 5.5%. The estimate compares to the year-ago value of 7%.

It is projected by analysts that the 'Organic Sales Growth (YoY change) - Total P&G' will reach 3.8%. Compared to the present estimate, the company reported 7% in the same quarter last year.

According to the collective judgment of analysts, 'Organic Sales Growth (YoY change) - Baby, Feminine & Family Care' should come in at 4.2%. The estimate compares to the year-ago value of 6%.

The consensus among analysts is that 'Organic Sales Growth (YoY change) - Fabric & Home Care' will reach 4.9%. Compared to the present estimate, the company reported 9% in the same quarter last year.

Analysts forecast 'Organic Sales Growth (YoY change) - Health Care' to reach 3.3%. The estimate is in contrast to the year-ago figure of 9%.

View all Key Company Metrics for P&G here>>>

Over the past month, shares of P&G have returned -3.6% versus the Zacks S&P 500 composite's -0.9% change. Currently, PG carries a Zacks Rank #4 (Sell), suggesting that it may underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Procter & Gamble Company (The) (PG) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research